Intensification therapy with autologous stem cell transplantation versus bortezomib-melphalan-prednisone for newly diagnosed multiple myeloma patients: A multicenter, phase III study of the european myeloma network (EMN02/HO95 MM trial)
Autor: | Tacchetti, P Beksac, M Dimopoulos, M Zamagni, E Di Raimondo, F Gay, F Hajek, R Marzocchi, G Cellini, C Mellqvist, UH others |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: | |
Databáze: | OpenAIRE |
Externí odkaz: |